Clinical Trial Update: Multiple-dose Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Pharmacodynamics of HSK7653 in T2DM [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating safety, tolerability, pharmacokinetics, and pharmacodynamics of HSK7653 in type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• HSK7653

Snippet

Sponsor: Haisco Pharmaceutical Group Co., Ltd. | Conditions: Type 2 Diabetes Mellitus | Phase 2 | Status: COMPLETED